Effectiveness and outcomes of thermablate endometrial ablation system in women with heavy menstrual bleeding

Ghadeer Al-Shaikh, Ghada Almalki, Mujahed Bukhari, Amel Fayed, Hazem Al-Mandeel

Research output: Contribution to journalArticleResearchpeer-review

1 Citation (Scopus)

Abstract

Heavy menstrual bleeding (HMB) is a common problem in women of reproductive age group with major impact on their quality of life (QoL). The aim was to study the short-term effectiveness of Thermablate Endometrial Ablation System (EAS) and its impact on QoL in women with HMB. This was a prospective cohort study conducted on consecutive 72 women suffering from HMB. The success rate was estimated and patients’ QoL was compared before and after the procedure using the Aberdeen menorrhagia severity scale. The mean follow-up period was 18 months (6–24 months). The mean age and body mass index were 48 (±5.2) years 33.2 (±7.4) kg/m2 respectively. Among treated participants, 58 (80.6%) reported the absence of bleeding. A significant decrease was observed in the rate of missed social activity and increase in the leisure time activities. The overall patient satisfaction was 95.7%. Thermablate EAS is an effective minimally invasive treatment with marked improvement in QoL in women with HMB.Impact statement Heavy menstrual bleeding (HMB) is a common problem that affects 11–13% of reproductive age women with major impact on their quality of life (QoL). A variety of methods for endometrial ablation has been used for the destruction of the endometrial lining to treat HMB. The short-term results of this study shows amenorrhoea rate of (80.6%) after the procedure and a significant decrease in the rate of missed social activity and increase in the leisure time activities with marked improvement in QoL. The overall patient satisfaction was 95.7%. Thermablate Endometrial Ablation System is an effective minimally invasive treatment for HMB with advantages of shorter operating time, shorter hospital stay and high-level patient satisfaction. However, further clinical research with large-scale studies and possible comparison with other treatment options are recommended.

Original languageEnglish
Pages (from-to)770-774
Number of pages5
JournalJournal of Obstetrics and Gynaecology
Volume37
Issue number6
DOIs
Publication statusPublished - 18 Aug 2017

Fingerprint

Endometrial Ablation Techniques
Hemorrhage
Quality of Life
Patient Satisfaction
Leisure Activities
Menorrhagia
Amenorrhea
Length of Stay
Body Mass Index
Cohort Studies
Therapeutics
Age Groups
Prospective Studies

Keywords

  • Abnormal uterine bleeding
  • endometrial balloon ablation
  • heavy menstrual bleeding
  • quality of life
  • thermablate endometrial ablation system

Cite this

Al-Shaikh, Ghadeer ; Almalki, Ghada ; Bukhari, Mujahed ; Fayed, Amel ; Al-Mandeel, Hazem. / Effectiveness and outcomes of thermablate endometrial ablation system in women with heavy menstrual bleeding. In: Journal of Obstetrics and Gynaecology. 2017 ; Vol. 37, No. 6. pp. 770-774.
@article{6977b905181a4074ba6e80e80fb412e7,
title = "Effectiveness and outcomes of thermablate endometrial ablation system in women with heavy menstrual bleeding",
abstract = "Heavy menstrual bleeding (HMB) is a common problem in women of reproductive age group with major impact on their quality of life (QoL). The aim was to study the short-term effectiveness of Thermablate Endometrial Ablation System (EAS) and its impact on QoL in women with HMB. This was a prospective cohort study conducted on consecutive 72 women suffering from HMB. The success rate was estimated and patients’ QoL was compared before and after the procedure using the Aberdeen menorrhagia severity scale. The mean follow-up period was 18 months (6–24 months). The mean age and body mass index were 48 (±5.2) years 33.2 (±7.4) kg/m2 respectively. Among treated participants, 58 (80.6{\%}) reported the absence of bleeding. A significant decrease was observed in the rate of missed social activity and increase in the leisure time activities. The overall patient satisfaction was 95.7{\%}. Thermablate EAS is an effective minimally invasive treatment with marked improvement in QoL in women with HMB.Impact statement Heavy menstrual bleeding (HMB) is a common problem that affects 11–13{\%} of reproductive age women with major impact on their quality of life (QoL). A variety of methods for endometrial ablation has been used for the destruction of the endometrial lining to treat HMB. The short-term results of this study shows amenorrhoea rate of (80.6{\%}) after the procedure and a significant decrease in the rate of missed social activity and increase in the leisure time activities with marked improvement in QoL. The overall patient satisfaction was 95.7{\%}. Thermablate Endometrial Ablation System is an effective minimally invasive treatment for HMB with advantages of shorter operating time, shorter hospital stay and high-level patient satisfaction. However, further clinical research with large-scale studies and possible comparison with other treatment options are recommended.",
keywords = "Abnormal uterine bleeding, endometrial balloon ablation, heavy menstrual bleeding, quality of life, thermablate endometrial ablation system",
author = "Ghadeer Al-Shaikh and Ghada Almalki and Mujahed Bukhari and Amel Fayed and Hazem Al-Mandeel",
year = "2017",
month = "8",
day = "18",
doi = "10.1080/01443615.2017.1292228",
language = "English",
volume = "37",
pages = "770--774",
journal = "Journal of Obstetrics and Gynaecology",
issn = "0144-3615",
publisher = "Informa Healthcare",
number = "6",

}

Effectiveness and outcomes of thermablate endometrial ablation system in women with heavy menstrual bleeding. / Al-Shaikh, Ghadeer; Almalki, Ghada; Bukhari, Mujahed; Fayed, Amel; Al-Mandeel, Hazem.

In: Journal of Obstetrics and Gynaecology, Vol. 37, No. 6, 18.08.2017, p. 770-774.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Effectiveness and outcomes of thermablate endometrial ablation system in women with heavy menstrual bleeding

AU - Al-Shaikh, Ghadeer

AU - Almalki, Ghada

AU - Bukhari, Mujahed

AU - Fayed, Amel

AU - Al-Mandeel, Hazem

PY - 2017/8/18

Y1 - 2017/8/18

N2 - Heavy menstrual bleeding (HMB) is a common problem in women of reproductive age group with major impact on their quality of life (QoL). The aim was to study the short-term effectiveness of Thermablate Endometrial Ablation System (EAS) and its impact on QoL in women with HMB. This was a prospective cohort study conducted on consecutive 72 women suffering from HMB. The success rate was estimated and patients’ QoL was compared before and after the procedure using the Aberdeen menorrhagia severity scale. The mean follow-up period was 18 months (6–24 months). The mean age and body mass index were 48 (±5.2) years 33.2 (±7.4) kg/m2 respectively. Among treated participants, 58 (80.6%) reported the absence of bleeding. A significant decrease was observed in the rate of missed social activity and increase in the leisure time activities. The overall patient satisfaction was 95.7%. Thermablate EAS is an effective minimally invasive treatment with marked improvement in QoL in women with HMB.Impact statement Heavy menstrual bleeding (HMB) is a common problem that affects 11–13% of reproductive age women with major impact on their quality of life (QoL). A variety of methods for endometrial ablation has been used for the destruction of the endometrial lining to treat HMB. The short-term results of this study shows amenorrhoea rate of (80.6%) after the procedure and a significant decrease in the rate of missed social activity and increase in the leisure time activities with marked improvement in QoL. The overall patient satisfaction was 95.7%. Thermablate Endometrial Ablation System is an effective minimally invasive treatment for HMB with advantages of shorter operating time, shorter hospital stay and high-level patient satisfaction. However, further clinical research with large-scale studies and possible comparison with other treatment options are recommended.

AB - Heavy menstrual bleeding (HMB) is a common problem in women of reproductive age group with major impact on their quality of life (QoL). The aim was to study the short-term effectiveness of Thermablate Endometrial Ablation System (EAS) and its impact on QoL in women with HMB. This was a prospective cohort study conducted on consecutive 72 women suffering from HMB. The success rate was estimated and patients’ QoL was compared before and after the procedure using the Aberdeen menorrhagia severity scale. The mean follow-up period was 18 months (6–24 months). The mean age and body mass index were 48 (±5.2) years 33.2 (±7.4) kg/m2 respectively. Among treated participants, 58 (80.6%) reported the absence of bleeding. A significant decrease was observed in the rate of missed social activity and increase in the leisure time activities. The overall patient satisfaction was 95.7%. Thermablate EAS is an effective minimally invasive treatment with marked improvement in QoL in women with HMB.Impact statement Heavy menstrual bleeding (HMB) is a common problem that affects 11–13% of reproductive age women with major impact on their quality of life (QoL). A variety of methods for endometrial ablation has been used for the destruction of the endometrial lining to treat HMB. The short-term results of this study shows amenorrhoea rate of (80.6%) after the procedure and a significant decrease in the rate of missed social activity and increase in the leisure time activities with marked improvement in QoL. The overall patient satisfaction was 95.7%. Thermablate Endometrial Ablation System is an effective minimally invasive treatment for HMB with advantages of shorter operating time, shorter hospital stay and high-level patient satisfaction. However, further clinical research with large-scale studies and possible comparison with other treatment options are recommended.

KW - Abnormal uterine bleeding

KW - endometrial balloon ablation

KW - heavy menstrual bleeding

KW - quality of life

KW - thermablate endometrial ablation system

UR - http://www.scopus.com/inward/record.url?scp=85017610742&partnerID=8YFLogxK

U2 - 10.1080/01443615.2017.1292228

DO - 10.1080/01443615.2017.1292228

M3 - Article

VL - 37

SP - 770

EP - 774

JO - Journal of Obstetrics and Gynaecology

JF - Journal of Obstetrics and Gynaecology

SN - 0144-3615

IS - 6

ER -